Vaginal mesh is used by surgeons as a medical implant for the treatment of Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). Sufferers of these two debilitating conditions are women of old age who have had past histories of hysterectomies and menopauses. In addition, some young women are also at risk for these ailments, especially those who have had delivered vaginally before. With regards to this truth, the number of women introduced to the implantation of trans-vaginal mesh (TVM) is continuously rising.
As observed recently, many women across the United States were affected with Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). At first, the use of vaginal mesh gained the physicians’ and the consumers’ confidence since patient’s recovery from the symptoms of POP and SUI were strikingly fast, but after a few years, complaints of its complications started to pile up and increase at a rapid pace.
When was the vaginal mesh first used?
Used by most physicians as a surgical treatment for hernia, surgical meshes invaded the world of surgeries in the 1950’s. It was then used to repair POP and SUI in 1970; and in 199o, it was introduced as a vaginal implant for the treatment of the same conditions.
The use of vaginal implants has caused too much uproar among affected women who had developed irreversible complications from the implantation of the vaginal mesh, which resulted to the influx of vaginal mesh lawsuits all over the United States.
The most frequently reported complications linked to vaginal meshes are: erosion of the vaginal mesh, hemorrhage, infection, pelvic organ perforations, recurring prolapse, and urinary disabilities. These symptoms are benign at first, but these can be harmful in the long run and may need several procedures to repair; some of these may even be irreparable.
To date, the number of lawsuits recorded is indefinite, but with the increasing number of unsatisfied consumers, there’s no doubt that TVM lawsuits will continue to rise.
A safety warning on the use of vaginal mesh were issued by the U.S. Food and Drug Administration to all health care providers to ensure the benefits of TVM implants before considering them as treatment for their POP and SUI patients.
Even with the announcements made by the FDA, there are still many physicians performing them in the treatment of POP and SUI and manufacturers are still producing and selling them to healthcare facilities.
A consumer advocacy group called Public Citizen petitioned the FDA on August 25, 2011 for the recall of all non-absorbable vaginal mesh products. Recently, the FDA is still carefully investigating this issue, and encourages all health care providers and patients to actively participate in this investigation by reporting any complications of vaginally-implanted surgical mesh the first time it is observed.